A Science and Technology Blog
In all, 492 severe and serious AEFI have been classified by the AEFI Secretariat of the immunisation technical support unit (ITSU) at the Health Ministry. Classification has been completed for…
While it is unclear if pre-existing antibodies to adenovirus vector will affect vaccine efficacy, it is possible that repeated vaccination using adenovirus-based vaccine either as a booster or as annual vaccination, if the need arises, will result in reduced efficacy due to vector immunity.
The results have been posted on medRxiv preprint server. Preprints are yet to be peer-reviewed and published in scientific journals. Though measurements were made only till day 28 after the…
What are the main challenges in developing and testing booster vaccine doses to address the new variants? Each variant (and many more beyond the first three that have been widely…
The results were posted in a preprint server. Preprints are yet to be peer-reviewed and published in scientific journals. No studies were carried out to examine the efficacy of the…
On January 31, when 11 deaths of health-care and frontline workers were reported from across the country following administration of Serum Institute’s Covishield vaccine nearly two-dozen scientists and others wrote…
The data in the preprint show that vaccine efficacy was high when the interval between the two doses was two months and continued to increase with a longer dose interval.…
On the say day the release was sent out announcing the partnership with AstraZeneca, Oxford University also tweeted saying that the vaccine will be manufactured and distributed “on a not-for-profit basis…
